Atomic layering of high-temperature superconducting compounds has been employed to grow films of Bi2Sr2Ca2Cu3Ox, in situ, on SrTiO3 substrates. Atomic monolayers of the constituent atoms were sequentially deposited by shuttering the fluxes from thermal effusion cells, and oxidation of the film was accomplished using a beam of ozone. The films were superconducting as-grown, with complete resistive transitions as high as 86 K. Moreover, reflection high-energy electron diffraction patterns observed during growth, as well as post-growth analysis by x-ray diffraction and high-resolution scanning electron micrography, indicate the films to be single crystal and heteroepitaxial, with in-plane a-b twinning.
We have employed Rutherford backscattering spectroscopy and secondary ion mass spectrometry to characterize the ion implantation dose uniformity which can be achieved with plasma source ion implantation (PSII), a non-line-of-sight technique for ion implantation of nonplanar targets in nonsemiconductor applications. In order to characterize the dose uniformity achievable with PSII, four spherical Ti-6Al-4V targets were PSII implanted simultaneously as a 2×2 square array in a nitrogen plasma with density 3×109 cm−3 at an energy of 50 keV to a nominal dose of 3×1017 atoms/cm2. The measured root-mean-square variation of both the retained dose and the mean range was found to be less than 15%, which is well within the acceptable tolerance range for nonsemiconductor applications of ion implantation. Our results demonstrate that PSII can achieve acceptable dose uniformity on nonplanar targets without target manipulation, and that such uniformity can be achieved in a batch processing mode.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.